Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing

Sandra Dial1, Eugene Delabays, Martin Albert

  • 1Department of Critical Care, SMBD Jewish General Hospital, McGill University, Montreal, Quebec, Canada. sandra.dial@mcgill.ca

Insights

Risk factors for low intraoperative hematocrit and excessive bleeding after coronary artery bypass grafting differ. Managing these requires limiting hemodilution and ensuring surgical hemostasis.

Area of Science:

  • Cardiovascular Surgery
  • Anesthesiology
  • Hematology

Background:

  • Low intraoperative hematocrit and excessive postoperative bleeding are potential complications in coronary artery bypass grafting (CABG).
  • Identifying distinct risk factors for these two adverse events is crucial for improving patient outcomes.

Purpose of the Study:

  • To determine the incidence and risk factors for low intraoperative hematocrit levels.
  • To identify the incidence and risk factors for excessive postoperative bleeding.
  • To assess whether these risk factors are the same and their impact on blood product transfusions.

Main Methods:

  • Prospective cohort study of 613 adult patients undergoing CABG.
  • Data collected from October 2000 to March 2001 across three tertiary university-affiliated hospitals.
  • Multivariate analysis used to identify independent risk factors.

Main Results:

  • Low intraoperative hematocrit (<19%) occurred in 24% of on-pump vs. 4% of off-pump procedures.
  • Risk factors for low hematocrit included older age, female sex, lower preoperative hemoglobin, and longer bypass times.
  • Excessive postoperative hemorrhage (>1 L) occurred in 26% of on-pump and 25% of off-pump patients, associated with male sex and longer pump times, but not low hematocrit.

Conclusions:

  • Risk factors for low intraoperative hematocrit and excessive postoperative bleeding are distinct.
  • Strategies to reduce these complications should focus on limiting hemodilution, especially in at-risk female patients.
  • Careful surgical hemostasis is essential for minimizing postoperative bleeding.
Abstract

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...